Gynecologic Cancers

AYA Cancers

Questions discussed in this category

Do you routinely recommend completion hysterectomy with contralateral salpingo-oophorectomy for patients with a history of fertility-sparing staging for borderline tumor of the ovary who have since completed childbearing?

2 Answers available

What is your treatment approach for a pediatric patient with uterine embryonal rhabdomyosarcoma found after removal of a prolapsing uterine mass, with no evidence of distant metastasis on imaging?

1 Answer available

How do you approach hormone replacement therapy for premenopausal patients following pelvic radiation therapy?

How is your approach different from or similar to those who undergo surgical menopause?

1 Answer available

How would you approach an adolescent patient with stage IIIC serous borderline tumor, s/p fertility sparing surgical staging with unilateral salpingo-oophorectromy, who presents with an enlarging contralateral ovarian mass and additional pelvic disease on imaging?

1 Answer available

Papers discussed in this category

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006-02-01

Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study.

Obstet Gynecol, 1998 Oct

Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee.

Acta Oncol, 2019 Apr 08

Sex steroid hormone receptor expression in the vaginal wall in cervical cancer survivors after radiotherapy.

Gynecologic oncology, 1992-11

Long-term follow-up of serous ovarian tumors of low malignant potential.

Cancer, 1998-03-15

Ovarian serous borderline tumors with invasive peritoneal implants.

Cancer, 1998-11-15

Serous borderline tumors of the ovary with noninvasive peritoneal implants.

Cancer, 2004-03-01

Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.

Lancet Oncol, 2012 Mar

Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence.

Cancer, 1996 Jul 15

Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.

Gynecol Oncol, 2001 Apr

Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors.

J Clin Oncol, 2001 May 15

Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study.

J Clin Oncol, 2007 Jul 10

Management of borderline ovarian neoplasms.

Pediatric blood & cancer, 2018-02

Consensus and controversies regarding the treatment of rhabdomyosarcoma.

Related Topics in Gynecologic Cancers